• Policy
• Largest-ever drug pricing reeval to be conducted this year
• by Kim, Jung-Ju Jan 2, 2023 06:04am

• Policy
• SK Chemicals Riluzole is listed
• by Lee, Tak-Sun Jan 2, 2023 06:04am

• Policy
• High conc Ultomiris Inj 100mg/mL also approved in Korea
• by Kim, Jung-Ju Jan 2, 2023 06:04am

• Policy
• Australia, excluding drug price reference countries
• by Lee, Tak-Sun Jan 1, 2023 10:40pm

• Policy
• New formulations of narcotics will be as strictly reviewed
• by Lee, Jeong-Hwan Dec 30, 2022 06:33am

• Policy
• Gov allocates KRW1.47 trillion budget for healthcare R&D
• by Kim, Jung-Ju Dec 30, 2022 06:33am

• Policy
• A rapid change in the population
• by Kang, Shin-Kook Dec 29, 2022 06:03am

• Policy
• Takeda CMV infection treatment Livtencity has been approved
• by Kim, Jung-Ju Dec 29, 2022 06:03am

• Policy
• Abbott’s Lipidil NT 145mg listed with reimbursement
• by Lee, Tak-Sun Dec 27, 2022 06:10am

• Policy
• Darzalex succeeded in renewing his contract with RSA
• by Kim, Jung-Ju Dec 26, 2022 06:07am